Weili Wang

Investment Associate

2021 - Current

Investment Analyst - Biotechnology

2020 - 2021

• Conduct technology and market due diligence for Healthcare and Life Science opportunities • Model financial forecast in income statement, balance sheet, and cash flow statement • Prepare internal investment proposal to the investment committee • Engage both internal and external stakeholders to achieve synergy and facilitate deal flow

Industrial Placement (Innovation and Digital Solution)

2019 - 2019

External Advisor - Bio-pharmaceutical Equity

2018 - 2019

• Identify buying opportunities among Chinese listed Bio-pharmaceutical stocks based on financial performance • Evaluate growth potential of the targeted stocks based on their clinical trial reports and current R&D pipelines • Provide buying/selling advice on stock trading in bio-pharmaceutical industry

Academic Tutor

2017 - 2018

FINM7401 Finance

Research Assistant

2018 - 2018

• Prepared input data for the development of machine learning algorithm • Summarized the sentiments of news articles on four Chinese listed companies, namely, Vanke, Petro China, China Telecom, and China Construction Bank from selected journals • Quantified the public sentiments in numerical terms

Commercial Engagement Intern

2015 - 2016

Senior Research Technician

2013 - 2015

• Conduct molecular biological analysis of human fetal stem cells. • Responsible for maintaining dedicated mice colonies to ensure compliance of appropriate ethical and legitimate standards. • Responsible for overall laboratory management and record keeping.

Research Technician

2013 - 2013

• Apply general molecular biology techniques for two research projects (Real-time PCR, Western blotting, Immunofluorescence, Immunoprecipitation, etc.) i. The role of cyclin A/cdk2 complex in late S/G2 phase of the cell cycle ii. Mechanisms that can bypass p16-induced senescence in melanoma • Conduct routine maintenance on specialized tissue culture equipment